| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 9, 2014
MINNEAPOLIS - January 9, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that its U.S. pivotal trial in renal denervation for treatment-resistant hypertension, SYMPLICITY HTN-3, failed to meet...
-
Jan 9, 2014New Therapeutic Device Company Launched by The Foundry
DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 9, 2014-- Covidien plc (NYSE: COV), Lightstone Ventures and New Enterprise Associates (NEA) will jointly invest in a new company launched by The Foundry, a...
-
Nov 25, 2013
Thomson Reuters ONE via COMTEX) --Presented at VEITH, Three-Year Clinical Data from Global ENGAGE Registry Supports Innovative Device's Market-Leading Position Worldwide MINNEAPOLIS -- Nov. 25,...
-
Nov 7, 2013
Thomson Reuters ONE via COMTEX) --LIA Software Proven to Detect Lead Failures More Frequently Than Impedance Alone on Riata, Durata and Endotak Leads MINNEAPOLIS - Nov. 7, 2013 - Medtronic, Inc....
-
Oct 29, 2013(Thomson Reuters ONE via COMTEX) --- Trial Finds Lifesaving Technology Successfully Meets Primary and Secondary Endpoints
SAN FRANCISCO and MINNEAPOLIS - Oct. 29, 2013 - Medtronic, Inc. (NYSE: MDT) today announced the highly anticipated results from the CoreValve U.S. Pivotal Trial, the first U.S. data presented on...